KYMR•benzinga•
UBS Maintains Buy on Kymera Therapeutics, Lowers Price Target to $74
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 4, 2024 by benzinga